S. Lao-Sirieix

747TiPSCHEDULING NAB-PACLITAXEL WITH GEMCITABINE (SIEGE): RANDOMISED PHASE II TRIAL TO INVESTIGATE TWO DIFFERENT SCHEDULES OF NAB-PACLITAXEL (ABX) COMBINED WITH GEMCITABINE (GEM) AS FIRST LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA (PDAC).

D. Jodrell, W. Qian, J. Valle, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

T. Meyer, D. Talbot, D. Cunningham, 2014, European journal of cancer.

Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery

S. Barclay, P. McCrone, A. Prevost, 2013, British Journal of Cancer.

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications

P. Corrie, A. M. Moody, D. Parashar, 2012, British Journal of Cancer.

Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial)

M. Barman, B. Prendergast, G. Angelini, 2018, Journal of the American Heart Association.

The heterodimeric primase of the hyperthermophilic archaeon Sulfolobus solfataricus possesses DNA and RNA primase, polymerase and 3'-terminal nucleotidyl transferase activities.

S. Bell, S. Lao-Sirieix, 2004, Journal of molecular biology.

Structure of the heterodimeric core primase

S. Bell, P. Roversi, L. Pellegrini, 2005, Nature Structural &Molecular Biology.

The promiscuous primase.

S. Bell, L. Pellegrini, S. Lao-Sirieix, 2005, Trends in genetics : TIG.

Neuroendocrine tumors and CUP

A. Carrato, M. Kudo, R. Salazar, 2012 .

Abstract CT248: AZD7648: A Phase I/IIa first-in-human trial of a novel, potent and selective DNA-PK inhibitor in patients with advanced malignancies

T. Yap, D. Landers, E. Cadogan, 2020, Tumor Biology.